The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs

Schreiber, Andre; Ambrosy, Benjamin; Planz, Oliver; Schloer, Sebastian; Rescher, Ursula; Ludwig, Stephan

dc.contributor.author	Planz, Oliver
dc.date.accessioned	2023-04-17T06:37:43Z
dc.date.available	2023-04-17T06:37:43Z
dc.date.issued	2022
dc.identifier.issn	1999-4923
dc.identifier.uri	http://hdl.handle.net/10900/139203
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/pharmaceutics14091776	de_DE
dc.subject.ddc	610	de_DE
dc.title	The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_01621
utue.personen.roh	Schreiber, Andre
utue.personen.roh	Ambrosy, Benjamin
utue.personen.roh	Planz, Oliver
utue.personen.roh	Schloer, Sebastian
utue.personen.roh	Rescher, Ursula
utue.personen.roh	Ludwig, Stephan
dcterms.isPartOf.ZSTitelID	Pharmaceutics	de_DE
dcterms.isPartOf.ZS-Issue	Article 1776	de_DE
dcterms.isPartOf.ZS-Volume	14 (9)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE